SHANGHAI, CHINA, April 26th, 2023—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as "BioPerfectus") is proud to announce the release of three new products: Nucleic Acid Extraction System SSNP-A6 (FDA-listed, CE-IVDR), Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method) (CE-IVDR) and Nucleic Acid Extraction and Purification Rapid Kit 96T (CE-IVDR ). Designed for high efficiency and continuous high throughput, these products offer a rapid and automated solution for the extraction of nucleic acids.

SSNP-A6 is an in vitro diagnostic medical device, which integrates cutting-edge mechanical, electronic and software technologies. Compatible with Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method), SSNP-A6 enables automated extraction of nucleic acids from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc. Meanwhile, SSNP-A6 can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput.

Nucleic Acid Extraction and Purification Rapid Kit 96T is designed to work with the KingFisher Flex, KingFisher Apex, and other fully automated nucleic acid extraction systems produced by Thermo Fisher Scientific. It can efficiently extract from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc.

As a company dedicated to addressing the health challenges faced by humanity, BioPerfectus continues to embrace innovation and pursue excellence in the field of molecular diagnostics.